Essen University Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma

  2025-522563-15-00· 2/3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  A clinical trial to learn more about the effects of AAA817 given with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer

  2024-512340-32-01· 3. fázis· Novartis Pharma AG· Forrás

• Még nem toboroz

  Post-intervention dual antiplatelet therapy for mild stroke

  2026-525681-22-00· 3. fázis· Technische Universitaet Dresden· Forrás

• Toboroz

  A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors

  2024-518348-19-00· 1. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma

  NCT07825064· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Decompressive Craniectomy After Aneurysmal Subarachnoid Hemorrhage (DECIDE-SAH)

  NCT07872774· University Hospital, Essen· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.

  2026-525367-40-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL

  2025-522019-40-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

  2026-526026-40-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)

  NCT07843940· 1/2. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A study of benfo‑oxythiamine added to Pluvicto® in adults with advanced prostate cancer whose disease is stable after two prior Pluvicto® cycles

  2026-527059-25-00· 1/2. fázis· Benfovir AG· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

  NCT07775924· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

  NCT07700979· 3. fázis· Akeso· Forrás

• Toboroz

  Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer

  NCT07860047· 2. fázis· University Hospital Tuebingen· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  Health Behaviour and Readiness to Change After Myocardial Infarction: A Cross-sectional Survey

  NCT07785921· Kliniken Essen-Mitte· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

  NCT07680790· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD

  2026-525216-34-00· 2. fázis· Expedition Therapeutics Inc.· Forrás

• Toboroz

  A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.

  2025-523285-25-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

  NCT07587242· 3. fázis· Avidity Biosciences, Inc.· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung

  NCT07561645· 2. fázis· Technische Universität Dresden· Forrás

• Még nem toboroz

  NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

  NCT07178730· 3. fázis· Women's Cancer Study Group GmbH· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

  NCT07564141· 3. fázis· Genmab· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

  2025-524336-19-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  BGB-43395 in Combination with Letrozole versus CDK4/6i with Letrozole for Patients with Previously Untreated Advanced or Metastatic HR+/HER2- Breast Cancer

  NCT07492641· 3. fázis· BeOne Medicines I GmbH· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping

  2025-523087-20-00· 3. fázis· Avidity Biosciences Inc.· Forrás

• Még nem toboroz

  Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE)

  NCT07553650· Charite University, Berlin, Germany· Forrás

• Toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  NCT07365241· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· 3. fázis· Norges Teknisk-Naturvitenskapelige Universitet NTNU· Forrás

• Még nem toboroz

  PHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure

  2026-526261-14-00· 2. fázis· Therakos Europe Limited· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.

  2025-522138-29-00· 2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)

  2024-516896-34-00· 1/2. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  NCT07596849· 3. fázis· argenx· Forrás

• Felfüggesztve

  A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis

  NCT07547436· 2. fázis· Sanofi· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  PREFer

  NCT06916416· 2. fázis· University Of Cologne· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma

  2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás

Showing 50 of 502.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok49 toboroz
• Tüdőrák35 toboroz
• Prosztatarák25 toboroz
• Vastagbélrák23 toboroz
• Melanóma19 toboroz
• Áttétes emlőrák17 toboroz
• Akut limfoid leukémia (ALL)13 toboroz
• Máj- és epeúti rák13 toboroz
• Szarkóma12 toboroz
• Hasnyálmirigyrák11 toboroz
• Gyomor- és nyelőcsőrák10 toboroz
• Fej-nyaki daganatok9 toboroz
• Mielóma multiplex9 toboroz
• Akut mieloid leukémia (AML)8 toboroz
• Follikuláris limfóma8 toboroz
• Hodgkin-limfóma8 toboroz
• Petefészekrák8 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)7 toboroz
• Duchenne-izomdisztrófia7 toboroz
• Krónikus limfoid leukémia (CLL)7 toboroz
• Szívelégtelenség7 toboroz
• Tripla negatív emlőrák7 toboroz
• Amiloidózis6 toboroz
• Koszorúér-betegség6 toboroz
• Sclerosis multiplex (SM)6 toboroz
• Stroke (szélütés)6 toboroz
• Vesedaganat6 toboroz
• Glioblasztóma5 toboroz
• Hólyagrák5 toboroz
• Myasthenia gravis5 toboroz
• Neuroblasztóma5 toboroz
• Neuroendokrin daganatok5 toboroz
• Alzheimer-kór4 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)4 toboroz
• Méhtestrák4 toboroz
• Myotonic dystrophy4 toboroz
• Cisztás fibrózis3 toboroz
• HIV-fertőzés3 toboroz
• Köpenysejtes limfóma3 toboroz
• Liver cirrhosis3 toboroz
• Magas vérnyomás3 toboroz
• Spinális izomatrófia (SMA)3 toboroz
• Asztma2 toboroz
• Brain aneurysm2 toboroz
• Elhízás2 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• Immune thrombocytopenia (ITP)2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Krónikus vesebetegség2 toboroz
• Mielodiszplasztikus szindróma (MDS)2 toboroz
• Mild cognitive impairment2 toboroz
• Myocarditis2 toboroz
• Peripheral artery disease2 toboroz
• Pitvarfibrilláció2 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Aortic stenosis1 toboroz
• Bronchiectasis1 toboroz
• Cerebral palsy1 toboroz
• Coeliac disease1 toboroz
• Crohn-betegség1 toboroz
• Cushing's syndrome1 toboroz
• Cytomegalovirus infection1 toboroz
• Dilated cardiomyopathy1 toboroz
• Essential tremor1 toboroz
• Graves' disease1 toboroz
• Huntington-kór1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Lichen planus1 toboroz
• Méhnyakrák1 toboroz
• Meningioma1 toboroz
• Mezotelióma1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Nephrotic syndrome1 toboroz
• Pajzsmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Polycystic ovary syndrome1 toboroz
• Sarcoidosis1 toboroz
• Thalassaemia1 toboroz
• Vascular dementia1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Study Evaluating BFB759 in Atopic Dermatitis

  2025-521624-30-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

  NCT07288203· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás

• Toboroz

  A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

  NCT07160634· 3. fázis· Solid Biosciences Inc.· Forrás

• Lezárult

  [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

  NCT07238322· Telix Pharmaceuticals (Innovations) Pty Limited· Forrás

• Lezárult

  Neoadjuvant Lu-PSMA radioligand therapy and Ipilimumab in men with very high-risk prostate cancer (NEPI)

  2024-514386-19-00· 1. fázis· Universitaetsklinikum Essen AöR· Forrás

• Lezárult

  Phase 2b Randomized, Double-Blind Study with Phage for CF Subjects with Pseudomonas Lung Infection

  2024-519856-94-00· 2. fázis· Biomx Ltd.· Forrás

• Toboroz

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· 3. fázis· Takeda· Forrás

• Lezárult

  A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer (NeoTRACE)

  2024-517561-16-00· 2. fázis· AIO-Studien gGmbH· Forrás

• Toboroz

  Phase 2, Multicenter, Open label, Platform Study investigating Tarlatamab (AMG 757) in patients with Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), with biomarker analysis to characterize response/resistance (UNLOCK TARLATAMAB)

  2024-515847-47-00· 2. fázis· Institut Gustave Roussy· Forrás

• Lezárult

  A Phase 2 Study of PRT3789 in Combination with Pembrolizumab in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation

  NCT06682806· 2. fázis· Prelude Therapeutics Inc.· Forrás

• Lezárult

  Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria.

  2024-518786-10-01· 2. fázis· Evommune Inc.· Forrás

• Lezárult

  AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®

  NCT07308678· ConvaTec Inc.· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

  2024-512505-66-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· 3. fázis· Takeda· Forrás

• Lezárult

  An Open-Label, Multicentre Phase 1b/2a Clinical Trial of BI-1607, an Fc-Engineered Monoclonal Antibody to FcγRIIB (CD32b), in Combination with Ipilimumab and Pembrolizumab in Participants with Unresectable or Metastatic Melanoma

  2024-512670-10-00· 1/2. fázis· BioInvent International AB· Forrás

• Lezárult

  A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy

  2023-508998-85-00· 1. fázis· Boehringer Ingelheim International GmbH· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Amgen· Forrás

• Lezárult

  A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers

  2023-507674-41-00· 1. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

  NCT06544733· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Fut, nem toboroz

  A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

  NCT06422884· 2. fázis· Endeavor Biomedicines, Inc.· Forrás

• Lezárult

  A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

  NCT06534411· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.

  NCT06447506· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511360-87-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A study to see how safe and effective the drug Luveltamab Tazevibulin (STRO-002) is in treating infants and children under 12 years old with a specific type of acute myeloid leukemia (AML)

  2023-506240-16-00· 1/2. fázis· Sutro Biopharma Inc.· Forrás

• Lezárult

  Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )

  NCT06341712· 2. fázis· Ipsen Innovation· Forrás

• Lezárult

  A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

  NCT06431763· 4. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

  NCT05808764· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Sacituzumab Govitecan in Metastatic Colorectal Cancer

  NCT06243393· 2/3. fázis· University Hospital Heidelberg· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Dose Finding study to evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GSK1070806 SC injection in Adult Participants with Moderate to Severe Atopic Dermatitis

  NCT05999799· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Fut, nem toboroz

  Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

  NCT06216158· 3. fázis· University of Heidelberg Medical Center· Forrás

• Fut, nem toboroz

  Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

  NCT06004661· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· 3. fázis· AbbVie· Forrás

• Lezárult

  PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

  NCT06247163· University Hospital, Essen· Forrás

• Lezárult

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· 2. fázis· Sanofi· Forrás

• Lezárult

  Adaptive Radiotherapy in Patients With Gynecological Tumors

  NCT06230549· University Hospital, Essen· Forrás

• Lezárult

  A first-in-human trial of safety and efficacy of GEN3017 in subjects with Hodgkin lymphoma or non-Hodgkin lymphoma

  NCT06018129· 1/2. fázis· Genmab A/S· Forrás

• Lezárult

  A Study Evaluating the Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients with Surgically Resectable Hepatocellular Carcinoma (Morpheus-Neo HCC)

  2022-502840-11-00· 1/2. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  The PEERLESS II Study

  NCT06055920· Inari Medical· Forrás

• Lezárult

  Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer

  NCT05724602· 2. fázis· European Organisation For Research And Treatment Of Cancer· Forrás

• Lezárult

  Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

  NCT06214611· University Hospital, Essen· Forrás

• Fut, nem toboroz

  [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

  NCT05870579· 1. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin

  NCT06521190· 2. fázis· Acousia Therapeutics GmbH· Forrás

• Lezárult

  Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy

  2022-500897-32-00· 3. fázis· Cannaxan GmbH· Forrás

• Lezárult

  An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06021054· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

  NCT06045806· 3. fázis· Celgene· Forrás

• Lezárult

  Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

  NCT05748483· 3. fázis· AbbVie· Forrás

• Lezárult

  Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

  NCT05800964· 1. fázis· Amgen Inc.· Forrás

• Lezárult

  Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

  NCT06036836· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors

  2022-502787-20-00· 2. fázis· IO Biotech ApS· Forrás

Showing 50 of 213.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Melanóma98 munka · 52 vizsgálat
• Prosztatarák73 munka · 42 vizsgálat
• Szarkóma47 munka · 19 vizsgálat
• Hasnyálmirigyrák29 munka · 19 vizsgálat
• Akut mieloid leukémia (AML)26 munka · 19 vizsgálat
• Amiloidózis25 munka · 12 vizsgálat
• Hodgkin-limfóma23 munka · 15 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)15 munka · 11 vizsgálat
• Brain metastases15 munka · 0 vizsgálat
• Cisztás fibrózis15 munka · 11 vizsgálat
• Fej-nyaki daganatok14 munka · 23 vizsgálat
• Spinális izomatrófia (SMA)13 munka · 12 vizsgálat
• Bronchiectasis11 munka · 2 vizsgálat
• Pajzsmirigyrák11 munka · 4 vizsgálat
• Mieloproliferatív neopláziák11 munka · 9 vizsgálat
• Cytomegalovirus infection10 munka · 1 vizsgálat
• Follikuláris limfóma9 munka · 11 vizsgálat
• Myocarditis9 munka · 3 vizsgálat
• Brain aneurysm7 munka · 2 vizsgálat
• Mezotelióma6 munka · 5 vizsgálat
• Myasthenia gravis6 munka · 11 vizsgálat
• Friedreich-ataxia5 munka · 0 vizsgálat
• Aplastic anaemia5 munka · 0 vizsgálat
• Cushing's syndrome4 munka · 1 vizsgálat
• Köpenysejtes limfóma4 munka · 6 vizsgálat
• Wilson disease4 munka · 1 vizsgálat
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)3 munka · 2 vizsgálat